Overview

SI-6603 Versus Placebo in Patients With Lumbar Disc Herniation

Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether SI-6603 is effective in the treatment of lumbar disc herniation.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Seikagaku Corporation